Letter

A/H1N1 pandemic

Oseltamivir’s adverse events

BMJ 2009; 339 doi: 10.1136/bmj.b3249 (Published 11 August 2009)
Cite this as: BMJ 2009;339:b3249

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Mark Strong, research fellow in public health medicine1,
  2. Julia Burrows, specialist trainee in public health1,
  3. Paul Redgrave, deputy director of public health2
  1. 1ScHARR, University of Sheffield, Sheffield S1 4DA
  2. 2NHS Sheffield
  1. m.strong{at}sheffield.ac.uk

    Local community based surveillance in South Yorkshire during July 2009 indicates that only 11% (95% confidence interval 7% to 17%) of people with flu symptoms were positive for A/H1N1. Many patients who use the National Pandemic Flu Service may therefore be offered antiviral drugs unnecessarily with risk of adverse effects.1

    After …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular